Sugimoto, Satoru https://orcid.org/0000-0002-2691-3399
Mena, Hebe Agustina
Sansbury, Brian E. https://orcid.org/0000-0002-6339-2940
Kobayashi, Shio https://orcid.org/0000-0001-7243-6696
Tsuji, Tadataka https://orcid.org/0000-0002-2837-8246
Wang, Chih-Hao https://orcid.org/0000-0003-1704-1311
Yin, Xuanzhi
Huang, Tian Lian https://orcid.org/0000-0001-7999-1393
Kusuyama, Joji https://orcid.org/0000-0003-4054-1939
Kodani, Sean D.
Darcy, Justin
Profeta, Gerson https://orcid.org/0000-0001-6394-2263
Pereira, Nayara
Tanzi, Rudolph E.
Zhang, Can https://orcid.org/0000-0002-4340-5118
Serwold, Thomas https://orcid.org/0000-0002-7503-0293
Kokkotou, Efi
Goodyear, Laurie J. https://orcid.org/0000-0002-6299-2928
Cypess, Aaron M. https://orcid.org/0000-0002-5570-9346
Leiria, Luiz Osório https://orcid.org/0000-0001-9483-3705
Spite, Matthew https://orcid.org/0000-0002-8868-3648
Tseng, Yu-Hua https://orcid.org/0000-0003-2053-9559
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK099511, R01DK112283, R01DK122808, R01DK077097, R01DK102898, R01DK122808)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL106173)
Article History
Received: 3 August 2021
Accepted: 18 May 2022
First Online: 27 June 2022
Competing interests
: M.S. and Y.-H.T. are inventors of a pending provisional patent application related to maresin 2 and metabolic therapeutics.